Suppr超能文献

原发性人类恶性黑色素瘤消退和进展区域肿瘤浸润淋巴细胞中的克隆性T细胞反应。

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.

作者信息

thor Straten P, Becker J C, Seremet T, Bröcker E B, Zeuthen J

机构信息

Department of Tumor Cell Biology, Division of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.

出版信息

J Clin Invest. 1996 Jul 15;98(2):279-84. doi: 10.1172/JCI118790.

Abstract

The T cell receptor (TCR) BV variable (V) gene repertoire of tumor infiltrating lymphocytes (TIL) found in progressive and regressive regions of the same primary human melanomas were characterized by reverse transcription coupled polymerase chain reaction (RT-PCR). After surgery, the tumors were divided into different parts which were judged as regressive or progressive regions by visual inspection. Subsequently this diagnosis was confirmed by histology. From a total of four primary melanomas analyzed, 2 were drawn to be HLA-A2+. Only relatively few BV-gene families were expressed at significant levels in each of the samples. Comparison of the BV-expression in regressive versus progressive regions of the same tumor revealed major differences in all cases examined. Direct sequencing of RT-PCR products indicated that highly expressed BV-gene families were of clonal origin in both the regressive and progressive regions. Together, these data strongly suggest the occurrence of clonal T cell responses in both regressive and progressive areas of the same primary tumor. The differences in expression of certain BV-genes may correlate with the functional activity of certain populations of tumor-infiltrating T cells.

摘要

采用逆转录聚合酶链反应(RT-PCR)对同一原发性人类黑色素瘤进展期和消退期肿瘤浸润淋巴细胞(TIL)的T细胞受体(TCR)BV可变(V)基因库进行了表征。手术后,将肿瘤分成不同部分,通过肉眼检查判断为消退或进展区域。随后,这一诊断通过组织学得到证实。在总共分析的4例原发性黑色素瘤中,有2例被判定为HLA - A2 +。在每个样本中,只有相对较少的BV基因家族有显著表达。同一肿瘤消退区与进展区BV表达的比较显示,在所有检查的病例中都存在主要差异。RT-PCR产物的直接测序表明,在消退区和进展区中,高表达的BV基因家族均来源于克隆。这些数据共同有力地表明,在同一原发性肿瘤的消退区和进展区均发生了克隆性T细胞反应。某些BV基因表达的差异可能与某些肿瘤浸润T细胞群体的功能活性相关。

相似文献

引用本文的文献

8
T-cell clonotypes in cancer.癌症中的T细胞克隆型
J Transl Med. 2004 Apr 8;2(1):11. doi: 10.1186/1479-5876-2-11.
10
T cell receptor usage in malignant diseases.恶性疾病中T细胞受体的使用情况。
Springer Semin Immunopathol. 1999;21(1):19-35. doi: 10.1007/BF00815176.

本文引用的文献

3
HLA Class I nucleotide sequences, 1992.
Immunobiology. 1993 Jan;187(1-2):70-101. doi: 10.1016/S0171-2985(11)80246-9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验